Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Cattaneo

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Thrombosis and Haemostasis|April 12, 2011
Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphateMarco Cattaneo
Heart (British Cardiac Society)|December 30, 2010
What is the best dose of aspirin in association with P2Y12 antagonists?Marco Cattaneo
Archives of Internal Medicine|November 25, 2010
Prasugrel and cancerMarco Cattaneo
Clinical Chemistry|August 21, 2003
Homocysteine and the risk of intrauterine growth retardationMarco Cattaneo
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Antiplatelet agentsMarco Cattaneo
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2004
Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistanceMarco Cattaneo
Thrombosis Research|October 3, 2012
Mechanisms of variability in antiplatelet agents responseMarco Cattaneo
Drug News & Perspectives|August 31, 2006
ADP receptors: inhibitory strategies for antiplatelet therapyMarco Cattaneo
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Disorders of platelet function. Abnormalities of the platelet P2 receptorsMarco Cattaneo
Timely Topics in Medicine. Cardiovascular Diseases|October 27, 2006
ADP receptors: inhibitory strategies for antiplatelet therapyMarco Cattaneo
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|April 12, 2011
Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphateMarco Cattaneo
Heart (British Cardiac Society)|December 30, 2010
What is the best dose of aspirin in association with P2Y12 antagonists?Marco Cattaneo
Archives of Internal Medicine|November 25, 2010
Prasugrel and cancerMarco Cattaneo
Clinical Chemistry|August 21, 2003
Homocysteine and the risk of intrauterine growth retardationMarco Cattaneo
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Antiplatelet agentsMarco Cattaneo
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2004
Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistanceMarco Cattaneo
Thrombosis Research|October 3, 2012
Mechanisms of variability in antiplatelet agents responseMarco Cattaneo
Drug News & Perspectives|August 31, 2006
ADP receptors: inhibitory strategies for antiplatelet therapyMarco Cattaneo
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Disorders of platelet function. Abnormalities of the platelet P2 receptorsMarco Cattaneo
Timely Topics in Medicine. Cardiovascular Diseases|October 27, 2006
ADP receptors: inhibitory strategies for antiplatelet therapyMarco Cattaneo
Pageof 27